chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Aphasia, Atrial fibrillation, COVID-19 pneumonia, Chronic obstructive pulmonary disease
Clinical narrative: Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 8/26/2021. Patient presented to ED on 10/2/2021 for shortness of breath, coughing and wheezing. Patient has a week of feeling unwell, saying she has had worsening dyspnea on exertion, PND and orthopnea. She also mentions stopping all of her medications for two days when that happened because she was feeling too unwell. 4 days ago, her shortness of breath acutely worsened. She had been dusting and the dust made her wheezing and coughing worse. Shortness of breath became severe enough that she needed to come to the ED. The patient was admitted on 10/3 for COPD exacerbation and COVID pneumonia. She developed worsening hypoxemic respiratory failure with increasing HFNC requirements and was subsequently transferred to the ICU on 10/11. Her renal failure worsened so a femoral quinton was placed but the patient became very hypotensive and hypoxic with every attempt at HD or CRRT. The patient decided that she would not want to pursue intubation in the setting of further respiratory deterioration. Code status was changed to DNAR-COT. Since dialysis made the patient too hypoxic while already on HFNC, the decision was made to not pursue further dialysis and the quinton was removed. Then, the patient's pneumonia panel came back positive for pseudomonas and her respiratory culture indicated the presence of mold. She was started on cefepime and cresemba. Her oxygen requirements decreased and she was transferred back to the floor on 10/19. However, on 10/20 she was brought back to the ICU once again for worsening hypoxia requiring 60L/90% on HFNC. She also developed hemoptysis, anemia, and thrombocytopenia requiring transfusion of platelets and pRBCs. V/Q scan was negative for PE. On 10/23, the patient developed acute word finding difficulty while speaking with family member in the setting of a brief run of afib and ongoing thrombocytopenia. CT brain was ordered to assess for stroke/bleed. However, after discussion with the patient and her daughter, the decision was made to withdraw all support. She was made DNAR-AND and was started on comfort care.  On 10/24/2021, patient was pronounced deceased.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Culture positive, Death, Dyspnoea
Clinical narrative: Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 8/26/2021. Patient presented to ED on 10/2/2021 for shortness of breath, coughing and wheezing. Patient has a week of feeling unwell, saying she has had worsening dyspnea on exertion, PND and orthopnea. She also mentions stopping all of her medications for two days when that happened because she was feeling too unwell. 4 days ago, her shortness of breath acutely worsened. She had been dusting and the dust made her wheezing and coughing worse. Shortness of breath became severe enough that she needed to come to the ED. The patient was admitted on 10/3 for COPD exacerbation and COVID pneumonia. She developed worsening hypoxemic respiratory failure with increasing HFNC requirements and was subsequently transferred to the ICU on 10/11. Her renal failure worsened so a femoral quinton was placed but the patient became very hypotensive and hypoxic with every attempt at HD or CRRT. The patient decided that she would not want to pursue intubation in the setting of further respiratory deterioration. Code status was changed to DNAR-COT. Since dialysis made the patient too hypoxic while already on HFNC, the decision was made to not pursue further dialysis and the quinton was removed. Then, the patient's pneumonia panel came back positive for pseudomonas and her respiratory culture indicated the presence of mold. She was started on cefepime and cresemba. Her oxygen requirements decreased and she was transferred back to the floor on 10/19. However, on 10/20 she was brought back to the ICU once again for worsening hypoxia requiring 60L/90% on HFNC. She also developed hemoptysis, anemia, and thrombocytopenia requiring transfusion of platelets and pRBCs. V/Q scan was negative for PE. On 10/23, the patient developed acute word finding difficulty while speaking with family member in the setting of a brief run of afib and ongoing thrombocytopenia. CT brain was ordered to assess for stroke/bleed. However, after discussion with the patient and her daughter, the decision was made to withdraw all support. She was made DNAR-AND and was started on comfort care.  On 10/24/2021, patient was pronounced deceased.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea exertional, Dyspnoea paroxysmal nocturnal, Haemoptysis, Hypotension, Intensive care
Clinical narrative: Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 8/26/2021. Patient presented to ED on 10/2/2021 for shortness of breath, coughing and wheezing. Patient has a week of feeling unwell, saying she has had worsening dyspnea on exertion, PND and orthopnea. She also mentions stopping all of her medications for two days when that happened because she was feeling too unwell. 4 days ago, her shortness of breath acutely worsened. She had been dusting and the dust made her wheezing and coughing worse. Shortness of breath became severe enough that she needed to come to the ED. The patient was admitted on 10/3 for COPD exacerbation and COVID pneumonia. She developed worsening hypoxemic respiratory failure with increasing HFNC requirements and was subsequently transferred to the ICU on 10/11. Her renal failure worsened so a femoral quinton was placed but the patient became very hypotensive and hypoxic with every attempt at HD or CRRT. The patient decided that she would not want to pursue intubation in the setting of further respiratory deterioration. Code status was changed to DNAR-COT. Since dialysis made the patient too hypoxic while already on HFNC, the decision was made to not pursue further dialysis and the quinton was removed. Then, the patient's pneumonia panel came back positive for pseudomonas and her respiratory culture indicated the presence of mold. She was started on cefepime and cresemba. Her oxygen requirements decreased and she was transferred back to the floor on 10/19. However, on 10/20 she was brought back to the ICU once again for worsening hypoxia requiring 60L/90% on HFNC. She also developed hemoptysis, anemia, and thrombocytopenia requiring transfusion of platelets and pRBCs. V/Q scan was negative for PE. On 10/23, the patient developed acute word finding difficulty while speaking with family member in the setting of a brief run of afib and ongoing thrombocytopenia. CT brain was ordered to assess for stroke/bleed. However, after discussion with the patient and her daughter, the decision was made to withdraw all support. She was made DNAR-AND and was started on comfort care.  On 10/24/2021, patient was pronounced deceased.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Orthopnoea, Packed red blood cell transfusion, Platelet transfusion, Renal failure
Clinical narrative: Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 8/26/2021. Patient presented to ED on 10/2/2021 for shortness of breath, coughing and wheezing. Patient has a week of feeling unwell, saying she has had worsening dyspnea on exertion, PND and orthopnea. She also mentions stopping all of her medications for two days when that happened because she was feeling too unwell. 4 days ago, her shortness of breath acutely worsened. She had been dusting and the dust made her wheezing and coughing worse. Shortness of breath became severe enough that she needed to come to the ED. The patient was admitted on 10/3 for COPD exacerbation and COVID pneumonia. She developed worsening hypoxemic respiratory failure with increasing HFNC requirements and was subsequently transferred to the ICU on 10/11. Her renal failure worsened so a femoral quinton was placed but the patient became very hypotensive and hypoxic with every attempt at HD or CRRT. The patient decided that she would not want to pursue intubation in the setting of further respiratory deterioration. Code status was changed to DNAR-COT. Since dialysis made the patient too hypoxic while already on HFNC, the decision was made to not pursue further dialysis and the quinton was removed. Then, the patient's pneumonia panel came back positive for pseudomonas and her respiratory culture indicated the presence of mold. She was started on cefepime and cresemba. Her oxygen requirements decreased and she was transferred back to the floor on 10/19. However, on 10/20 she was brought back to the ICU once again for worsening hypoxia requiring 60L/90% on HFNC. She also developed hemoptysis, anemia, and thrombocytopenia requiring transfusion of platelets and pRBCs. V/Q scan was negative for PE. On 10/23, the patient developed acute word finding difficulty while speaking with family member in the setting of a brief run of afib and ongoing thrombocytopenia. CT brain was ordered to assess for stroke/bleed. However, after discussion with the patient and her daughter, the decision was made to withdraw all support. She was made DNAR-AND and was started on comfort care.  On 10/24/2021, patient was pronounced deceased.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory failure, Respiratory viral panel, Thrombocytopenia, Ventilation/perfusion scan normal, Wheezing
Clinical narrative: Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 8/26/2021. Patient presented to ED on 10/2/2021 for shortness of breath, coughing and wheezing. Patient has a week of feeling unwell, saying she has had worsening dyspnea on exertion, PND and orthopnea. She also mentions stopping all of her medications for two days when that happened because she was feeling too unwell. 4 days ago, her shortness of breath acutely worsened. She had been dusting and the dust made her wheezing and coughing worse. Shortness of breath became severe enough that she needed to come to the ED. The patient was admitted on 10/3 for COPD exacerbation and COVID pneumonia. She developed worsening hypoxemic respiratory failure with increasing HFNC requirements and was subsequently transferred to the ICU on 10/11. Her renal failure worsened so a femoral quinton was placed but the patient became very hypotensive and hypoxic with every attempt at HD or CRRT. The patient decided that she would not want to pursue intubation in the setting of further respiratory deterioration. Code status was changed to DNAR-COT. Since dialysis made the patient too hypoxic while already on HFNC, the decision was made to not pursue further dialysis and the quinton was removed. Then, the patient's pneumonia panel came back positive for pseudomonas and her respiratory culture indicated the presence of mold. She was started on cefepime and cresemba. Her oxygen requirements decreased and she was transferred back to the floor on 10/19. However, on 10/20 she was brought back to the ICU once again for worsening hypoxia requiring 60L/90% on HFNC. She also developed hemoptysis, anemia, and thrombocytopenia requiring transfusion of platelets and pRBCs. V/Q scan was negative for PE. On 10/23, the patient developed acute word finding difficulty while speaking with family member in the setting of a brief run of afib and ongoing thrombocytopenia. CT brain was ordered to assess for stroke/bleed. However, after discussion with the patient and her daughter, the decision was made to withdraw all support. She was made DNAR-AND and was started on comfort care.  On 10/24/2021, patient was pronounced deceased.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: pt did not have reaction to this. Pt was given the vaccine after beyond refrigeration date. Lot number was not expired.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Computerised tomogram thorax, Cough, Dyspnoea, Lung opacity
Clinical narrative: patient developed symptoms of COVID including shortness of breath, myalgia, fever and mild nonproductive cough and tested positive on 10/28/21
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Pulmonary hypertension, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: patient developed symptoms of COVID including shortness of breath, myalgia, fever and mild nonproductive cough and tested positive on 10/28/21
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Myalgia, Nausea
Clinical narrative: 3rd pregnancy, 2/10/22 due date.   Muscle aches, nausea and stomach pain for 4 days.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received Pfizer vaccine outside of the time frame.  Vaccine was diluted at 8:45AM, and after the six hours after dilution vial should have been thrown out, but it was not and patient received vaccine after the 6 hours.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Asthenia, Blood creatinine increased, Blood urea increased, COVID-19
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 3/31/2021 and 4/29/2021. Patient presented to outside facility ED on 9/30/2021 with chief complaint of feeling ill and fever of 2-3 days duration. Patient also had slight dry cough, diagnosed with COVID, and discharged home. On 10/2/2021 patient presented to ED with c/o SOB, chills, and generalized weakness that had been ongoing for 3 days PTA.  Pt had also had hematuria and increased urinary frequency. ED workup revealed BUN 24, sCr 1.4 and thrombocytopenia, While in ED, following the Regen-COV infusion  He became hypoxic requiring  15L/min O2 and syncopal episode lasting <30 seconds. He was admitted to med-surg for acute respiratory failure.  On 10/10, his clinical course was complicated by worsening respiratory distress and he was transferred to ICU for further management. On 10/14/2021 patient required intubation and mechanical ventilation support. On 10/23 patient required multiple vasopressor support. On 10/24 family decided to transition to comfort care and patient expired on 10/24/2021.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Death, Dyspnoea, Endotracheal intubation
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 3/31/2021 and 4/29/2021. Patient presented to outside facility ED on 9/30/2021 with chief complaint of feeling ill and fever of 2-3 days duration. Patient also had slight dry cough, diagnosed with COVID, and discharged home. On 10/2/2021 patient presented to ED with c/o SOB, chills, and generalized weakness that had been ongoing for 3 days PTA.  Pt had also had hematuria and increased urinary frequency. ED workup revealed BUN 24, sCr 1.4 and thrombocytopenia, While in ED, following the Regen-COV infusion  He became hypoxic requiring  15L/min O2 and syncopal episode lasting <30 seconds. He was admitted to med-surg for acute respiratory failure.  On 10/10, his clinical course was complicated by worsening respiratory distress and he was transferred to ICU for further management. On 10/14/2021 patient required intubation and mechanical ventilation support. On 10/23 patient required multiple vasopressor support. On 10/24 family decided to transition to comfort care and patient expired on 10/24/2021.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haematuria, Hypoxia, Intensive care, Malaise, Mechanical ventilation
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 3/31/2021 and 4/29/2021. Patient presented to outside facility ED on 9/30/2021 with chief complaint of feeling ill and fever of 2-3 days duration. Patient also had slight dry cough, diagnosed with COVID, and discharged home. On 10/2/2021 patient presented to ED with c/o SOB, chills, and generalized weakness that had been ongoing for 3 days PTA.  Pt had also had hematuria and increased urinary frequency. ED workup revealed BUN 24, sCr 1.4 and thrombocytopenia, While in ED, following the Regen-COV infusion  He became hypoxic requiring  15L/min O2 and syncopal episode lasting <30 seconds. He was admitted to med-surg for acute respiratory failure.  On 10/10, his clinical course was complicated by worsening respiratory distress and he was transferred to ICU for further management. On 10/14/2021 patient required intubation and mechanical ventilation support. On 10/23 patient required multiple vasopressor support. On 10/24 family decided to transition to comfort care and patient expired on 10/24/2021.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pollakiuria, Pyrexia, Respiratory distress, Syncope, Thrombocytopenia
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 3/31/2021 and 4/29/2021. Patient presented to outside facility ED on 9/30/2021 with chief complaint of feeling ill and fever of 2-3 days duration. Patient also had slight dry cough, diagnosed with COVID, and discharged home. On 10/2/2021 patient presented to ED with c/o SOB, chills, and generalized weakness that had been ongoing for 3 days PTA.  Pt had also had hematuria and increased urinary frequency. ED workup revealed BUN 24, sCr 1.4 and thrombocytopenia, While in ED, following the Regen-COV infusion  He became hypoxic requiring  15L/min O2 and syncopal episode lasting <30 seconds. He was admitted to med-surg for acute respiratory failure.  On 10/10, his clinical course was complicated by worsening respiratory distress and he was transferred to ICU for further management. On 10/14/2021 patient required intubation and mechanical ventilation support. On 10/23 patient required multiple vasopressor support. On 10/24 family decided to transition to comfort care and patient expired on 10/24/2021.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Contracted COVID-19 after being fully vaccinated.  Had the antibodies infusion.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Asthenia, COVID-19, Chills
Clinical narrative: I had cough, fever, chills, body aches, loss of taste and smell. I was very weak and fatigued. My oxygen levels were low. These symptoms lasted about four or five days. I had the cough for a few weeks. I took a home COVID 19 test, positive result. Then I went to my doctor, took another COVID 19 test, positive results.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Oxygen saturation decreased, Pain, Pyrexia
Clinical narrative: I had cough, fever, chills, body aches, loss of taste and smell. I was very weak and fatigued. My oxygen levels were low. These symptoms lasted about four or five days. I had the cough for a few weeks. I took a home COVID 19 test, positive result. Then I went to my doctor, took another COVID 19 test, positive results.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had cough, fever, chills, body aches, loss of taste and smell. I was very weak and fatigued. My oxygen levels were low. These symptoms lasted about four or five days. I had the cough for a few weeks. I took a home COVID 19 test, positive result. Then I went to my doctor, took another COVID 19 test, positive results.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given half of the J&J booster dose. 63-year-old male came in for J&J booster. Patient was given 0.25mL of J&J instead of 0.5mL. MD notified and recommended no additional doses needed.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Unresponsive to stimuli
Clinical narrative: Resident developed fever or 101.9 and unresponsive. Was sent to Hospital and admitted.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Emotional distress, Feeling abnormal, Headache, Myalgia
Clinical narrative: After receiving the injection I began to have severe body pain to include extreme headache, muscle aches, and fever which lasted about 24 hours. Since then I have not felt right physically (my equilibrium/balance) and my head has felt I guess the best wat to describe it is foggy it has been hard to think clearly and it seems like even my emotions are off I have been very emotional, which is very abnormal for me. I have not seen a doctor yet as I am hoping it clears up in the near future but just wanted to report it in case it doesn't.  I guess my biggest concern is the brain fog feeling that doesn't seem to be clearing up.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: After receiving the injection I began to have severe body pain to include extreme headache, muscle aches, and fever which lasted about 24 hours. Since then I have not felt right physically (my equilibrium/balance) and my head has felt I guess the best wat to describe it is foggy it has been hard to think clearly and it seems like even my emotions are off I have been very emotional, which is very abnormal for me. I have not seen a doctor yet as I am hoping it clears up in the near future but just wanted to report it in case it doesn't.  I guess my biggest concern is the brain fog feeling that doesn't seem to be clearing up.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Agitation, Asthenia, Back pain, Brain herniation, COVID-19
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/2/2021 and 3/24/2021.  Presented to ED on 10/22/2021 for evaluation of weakness that resulted in falls yesterday and today with associated upper back and neck pain. Pt is unable to give a complete ROS. States that he got COVID from his wife but does not know when his symptoms started, endorses a cough with green sputum for "a long time", weakness, and upper back and neck pain from fall. He states that he is so weak he is unable to stand up. Denies n/v, diarrhea, CP, SOB, ABD pain, ROS otherwise limited. PT extremely HOH. EMS reported O2 sat 90% on RA at home. Patient started on dexamethasone and remdesivir. Further history from patient indicated his prior diagnosis of bacterial of PNA was done over the phone. His imaging findings were consistent with bacterial PNA, he had no WBC and a relatively unimpressive procal, bacterial PNA was unlikely so abx were stopped. The following day patient became agitated and confused. He was alert only to himself but still attempted to converse and answer questions, he had no focal neurological signs. This was thought to be delirium from COVID-19, his UA was negative and his CXR was negative for aspiration and he did not show signs of sepsis. The following morning patient was obtunded and would not respond to sternal rub, he had nonreactive pupils. A stat CT head was ordered which revealed a massive extra-cranial bleed with 5 cm midline shift and subfalcine as well as uncal herniation. The bleed was most likely epidural or subdural in origin.  Family elected to make patient comfort care and patient expired on 10/26/2021.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Computerised tomogram head abnormal, Confusional state, Death, Depressed level of consciousness
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/2/2021 and 3/24/2021.  Presented to ED on 10/22/2021 for evaluation of weakness that resulted in falls yesterday and today with associated upper back and neck pain. Pt is unable to give a complete ROS. States that he got COVID from his wife but does not know when his symptoms started, endorses a cough with green sputum for "a long time", weakness, and upper back and neck pain from fall. He states that he is so weak he is unable to stand up. Denies n/v, diarrhea, CP, SOB, ABD pain, ROS otherwise limited. PT extremely HOH. EMS reported O2 sat 90% on RA at home. Patient started on dexamethasone and remdesivir. Further history from patient indicated his prior diagnosis of bacterial of PNA was done over the phone. His imaging findings were consistent with bacterial PNA, he had no WBC and a relatively unimpressive procal, bacterial PNA was unlikely so abx were stopped. The following day patient became agitated and confused. He was alert only to himself but still attempted to converse and answer questions, he had no focal neurological signs. This was thought to be delirium from COVID-19, his UA was negative and his CXR was negative for aspiration and he did not show signs of sepsis. The following morning patient was obtunded and would not respond to sternal rub, he had nonreactive pupils. A stat CT head was ordered which revealed a massive extra-cranial bleed with 5 cm midline shift and subfalcine as well as uncal herniation. The bleed was most likely epidural or subdural in origin.  Family elected to make patient comfort care and patient expired on 10/26/2021.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysstasia, Epidural haemorrhage, Fall, Hypoacusis, Imaging procedure abnormal
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/2/2021 and 3/24/2021.  Presented to ED on 10/22/2021 for evaluation of weakness that resulted in falls yesterday and today with associated upper back and neck pain. Pt is unable to give a complete ROS. States that he got COVID from his wife but does not know when his symptoms started, endorses a cough with green sputum for "a long time", weakness, and upper back and neck pain from fall. He states that he is so weak he is unable to stand up. Denies n/v, diarrhea, CP, SOB, ABD pain, ROS otherwise limited. PT extremely HOH. EMS reported O2 sat 90% on RA at home. Patient started on dexamethasone and remdesivir. Further history from patient indicated his prior diagnosis of bacterial of PNA was done over the phone. His imaging findings were consistent with bacterial PNA, he had no WBC and a relatively unimpressive procal, bacterial PNA was unlikely so abx were stopped. The following day patient became agitated and confused. He was alert only to himself but still attempted to converse and answer questions, he had no focal neurological signs. This was thought to be delirium from COVID-19, his UA was negative and his CXR was negative for aspiration and he did not show signs of sepsis. The following morning patient was obtunded and would not respond to sternal rub, he had nonreactive pupils. A stat CT head was ordered which revealed a massive extra-cranial bleed with 5 cm midline shift and subfalcine as well as uncal herniation. The bleed was most likely epidural or subdural in origin.  Family elected to make patient comfort care and patient expired on 10/26/2021.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Productive cough, Pupil fixed, SARS-CoV-2 test positive, Sputum discoloured
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/2/2021 and 3/24/2021.  Presented to ED on 10/22/2021 for evaluation of weakness that resulted in falls yesterday and today with associated upper back and neck pain. Pt is unable to give a complete ROS. States that he got COVID from his wife but does not know when his symptoms started, endorses a cough with green sputum for "a long time", weakness, and upper back and neck pain from fall. He states that he is so weak he is unable to stand up. Denies n/v, diarrhea, CP, SOB, ABD pain, ROS otherwise limited. PT extremely HOH. EMS reported O2 sat 90% on RA at home. Patient started on dexamethasone and remdesivir. Further history from patient indicated his prior diagnosis of bacterial of PNA was done over the phone. His imaging findings were consistent with bacterial PNA, he had no WBC and a relatively unimpressive procal, bacterial PNA was unlikely so abx were stopped. The following day patient became agitated and confused. He was alert only to himself but still attempted to converse and answer questions, he had no focal neurological signs. This was thought to be delirium from COVID-19, his UA was negative and his CXR was negative for aspiration and he did not show signs of sepsis. The following morning patient was obtunded and would not respond to sternal rub, he had nonreactive pupils. A stat CT head was ordered which revealed a massive extra-cranial bleed with 5 cm midline shift and subfalcine as well as uncal herniation. The bleed was most likely epidural or subdural in origin.  Family elected to make patient comfort care and patient expired on 10/26/2021.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Subdural haemorrhage, Urine analysis normal
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/2/2021 and 3/24/2021.  Presented to ED on 10/22/2021 for evaluation of weakness that resulted in falls yesterday and today with associated upper back and neck pain. Pt is unable to give a complete ROS. States that he got COVID from his wife but does not know when his symptoms started, endorses a cough with green sputum for "a long time", weakness, and upper back and neck pain from fall. He states that he is so weak he is unable to stand up. Denies n/v, diarrhea, CP, SOB, ABD pain, ROS otherwise limited. PT extremely HOH. EMS reported O2 sat 90% on RA at home. Patient started on dexamethasone and remdesivir. Further history from patient indicated his prior diagnosis of bacterial of PNA was done over the phone. His imaging findings were consistent with bacterial PNA, he had no WBC and a relatively unimpressive procal, bacterial PNA was unlikely so abx were stopped. The following day patient became agitated and confused. He was alert only to himself but still attempted to converse and answer questions, he had no focal neurological signs. This was thought to be delirium from COVID-19, his UA was negative and his CXR was negative for aspiration and he did not show signs of sepsis. The following morning patient was obtunded and would not respond to sternal rub, he had nonreactive pupils. A stat CT head was ordered which revealed a massive extra-cranial bleed with 5 cm midline shift and subfalcine as well as uncal herniation. The bleed was most likely epidural or subdural in origin.  Family elected to make patient comfort care and patient expired on 10/26/2021.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest X-ray, Chest pain, Electrocardiogram, Injection site pain
Clinical narrative: Unable to move arm Body aches Pain at injection site Muscle ache (From neck to right arm, back pain, chest pain)
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Myalgia, Neck pain, Pain, Pain in extremity
Clinical narrative: Unable to move arm Body aches Pain at injection site Muscle ache (From neck to right arm, back pain, chest pain)
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin
Clinical narrative: Unable to move arm Body aches Pain at injection site Muscle ache (From neck to right arm, back pain, chest pain)
Age: 60.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Chills, Extra dose administered, Headache, Pyrexia
Clinical narrative: Woke up with a headache the day after the vaccine (0800). Took a nap about 1100. Woke up at 1230 with chills. Checked my temperature around 1400 and had a 101.1 fever. My normal temp is below 98. Around 1900 took and antihistamine, decongestant and ibuprofen (600mg). Went to bed around 2200. Fever broke during the night and woke up feeling normal on 29 oct 2021. I did not have any adverse effects from the first two shots in March 2021.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaemia, Aortic stenosis, Atrial fibrillation, Blood lactic acid increased, Body temperature decreased
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/27/2021 and 2/22/2021, and 8/31/2021. Patient presented to ED on 10/15/2021 with complaints of cough & SOB x 2 weeks - diagnosed with covid PNA 2d prior prescribed doxycycline. Pt presents today because he reports he was coughing and had sharp pain at center of chest/ xiphoid process. Pt transferred to the ICU due to increasing oxygen requirements from COVID pneumonia. Pt also found to be anemic at that time and transfused 1 unit w/ improvement in Hgb levels. Pt had a history of aortic stenosis so a TTE was performed which revealed severe aortic stenosis, which significantly increased his chances of a difficult intubation due to poor cardiopulmonary reserve. Pt subsequently began developing worsened respiratory status and required intubation. Pt then developed worsening renal failure requiring CRRT. CRRT caused pt to become extremely hypotensive despite being on 3 pressors and near max. Pt also developed afib w/ RVR and had to be started on amio gtt. CRRT was paused and initially BP recovered without use of pressors, however over the course of a few hours pressors had to be added back. Pt also began having elevation of lactic acid, low temperatures, and elevated WBC so was re-cultured at that time. Family decided at that time they would like to allow patient to have comfort care, and patient expired on 10/26/2021
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest pain, Condition aggravated, Cough
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/27/2021 and 2/22/2021, and 8/31/2021. Patient presented to ED on 10/15/2021 with complaints of cough & SOB x 2 weeks - diagnosed with covid PNA 2d prior prescribed doxycycline. Pt presents today because he reports he was coughing and had sharp pain at center of chest/ xiphoid process. Pt transferred to the ICU due to increasing oxygen requirements from COVID pneumonia. Pt also found to be anemic at that time and transfused 1 unit w/ improvement in Hgb levels. Pt had a history of aortic stenosis so a TTE was performed which revealed severe aortic stenosis, which significantly increased his chances of a difficult intubation due to poor cardiopulmonary reserve. Pt subsequently began developing worsened respiratory status and required intubation. Pt then developed worsening renal failure requiring CRRT. CRRT caused pt to become extremely hypotensive despite being on 3 pressors and near max. Pt also developed afib w/ RVR and had to be started on amio gtt. CRRT was paused and initially BP recovered without use of pressors, however over the course of a few hours pressors had to be added back. Pt also began having elevation of lactic acid, low temperatures, and elevated WBC so was re-cultured at that time. Family decided at that time they would like to allow patient to have comfort care, and patient expired on 10/26/2021
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death, Dyspnoea, Echocardiogram, Endotracheal intubation, Haemofiltration
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/27/2021 and 2/22/2021, and 8/31/2021. Patient presented to ED on 10/15/2021 with complaints of cough & SOB x 2 weeks - diagnosed with covid PNA 2d prior prescribed doxycycline. Pt presents today because he reports he was coughing and had sharp pain at center of chest/ xiphoid process. Pt transferred to the ICU due to increasing oxygen requirements from COVID pneumonia. Pt also found to be anemic at that time and transfused 1 unit w/ improvement in Hgb levels. Pt had a history of aortic stenosis so a TTE was performed which revealed severe aortic stenosis, which significantly increased his chances of a difficult intubation due to poor cardiopulmonary reserve. Pt subsequently began developing worsened respiratory status and required intubation. Pt then developed worsening renal failure requiring CRRT. CRRT caused pt to become extremely hypotensive despite being on 3 pressors and near max. Pt also developed afib w/ RVR and had to be started on amio gtt. CRRT was paused and initially BP recovered without use of pressors, however over the course of a few hours pressors had to be added back. Pt also began having elevation of lactic acid, low temperatures, and elevated WBC so was re-cultured at that time. Family decided at that time they would like to allow patient to have comfort care, and patient expired on 10/26/2021
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypotension, Intensive care, Renal failure, SARS-CoV-2 test positive, Transfusion
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/27/2021 and 2/22/2021, and 8/31/2021. Patient presented to ED on 10/15/2021 with complaints of cough & SOB x 2 weeks - diagnosed with covid PNA 2d prior prescribed doxycycline. Pt presents today because he reports he was coughing and had sharp pain at center of chest/ xiphoid process. Pt transferred to the ICU due to increasing oxygen requirements from COVID pneumonia. Pt also found to be anemic at that time and transfused 1 unit w/ improvement in Hgb levels. Pt had a history of aortic stenosis so a TTE was performed which revealed severe aortic stenosis, which significantly increased his chances of a difficult intubation due to poor cardiopulmonary reserve. Pt subsequently began developing worsened respiratory status and required intubation. Pt then developed worsening renal failure requiring CRRT. CRRT caused pt to become extremely hypotensive despite being on 3 pressors and near max. Pt also developed afib w/ RVR and had to be started on amio gtt. CRRT was paused and initially BP recovered without use of pressors, however over the course of a few hours pressors had to be added back. Pt also began having elevation of lactic acid, low temperatures, and elevated WBC so was re-cultured at that time. Family decided at that time they would like to allow patient to have comfort care, and patient expired on 10/26/2021
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/27/2021 and 2/22/2021, and 8/31/2021. Patient presented to ED on 10/15/2021 with complaints of cough & SOB x 2 weeks - diagnosed with covid PNA 2d prior prescribed doxycycline. Pt presents today because he reports he was coughing and had sharp pain at center of chest/ xiphoid process. Pt transferred to the ICU due to increasing oxygen requirements from COVID pneumonia. Pt also found to be anemic at that time and transfused 1 unit w/ improvement in Hgb levels. Pt had a history of aortic stenosis so a TTE was performed which revealed severe aortic stenosis, which significantly increased his chances of a difficult intubation due to poor cardiopulmonary reserve. Pt subsequently began developing worsened respiratory status and required intubation. Pt then developed worsening renal failure requiring CRRT. CRRT caused pt to become extremely hypotensive despite being on 3 pressors and near max. Pt also developed afib w/ RVR and had to be started on amio gtt. CRRT was paused and initially BP recovered without use of pressors, however over the course of a few hours pressors had to be added back. Pt also began having elevation of lactic acid, low temperatures, and elevated WBC so was re-cultured at that time. Family decided at that time they would like to allow patient to have comfort care, and patient expired on 10/26/2021
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaemia, COVID-19, COVID-19 pneumonia, Cardiac failure acute, Death
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 2/2/2021 and 3/2/2021. Presented on 10/13/21 with dyspnea and hypoxia. Diagnosed with acute/chronic CHF, anemia and COVID pneumonia. Aggressively managed but failed to respond. Family opted for comfort care rather than continued aggressive management and she was admitted to hospice for end of life care.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 2/2/2021 and 3/2/2021. Presented on 10/13/21 with dyspnea and hypoxia. Diagnosed with acute/chronic CHF, anemia and COVID pneumonia. Aggressively managed but failed to respond. Family opted for comfort care rather than continued aggressive management and she was admitted to hospice for end of life care.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Fluid retention, Inflammation, Pain in extremity
Clinical narrative: Began with pain at the opposite side of the body in the extermities but today I have an inflamation, like if I am retaining liquid, under the left side (vaccination side) of the left arm
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Respiratory disorder
Clinical narrative: Pt. came in with difficulty breathing, cough, and respiratory issues; Pt. is on Zinc Sulfate, Pantoprazole; Lovenox; Vitamin C; Inpatient
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: pt did not have a reaction to this. Pt was given the vaccine after beyond use of refrigeration time. But lot number was not expired.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, COVID-19, Diarrhoea, Nausea, SARS-CoV-2 test positive
Clinical narrative: Patient presented to emergency department on 10/4/2021 with nausea, vomiting, diarrhea, and abdominal pain. She tested positive for COVID-19 at a different facility on 10/2/2021 and received monoclonal antibodies. Patient was admitted for further management. Patient was discharged home with home health care on 10/8/2021.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Patient presented to emergency department on 10/4/2021 with nausea, vomiting, diarrhea, and abdominal pain. She tested positive for COVID-19 at a different facility on 10/2/2021 and received monoclonal antibodies. Patient was admitted for further management. Patient was discharged home with home health care on 10/8/2021.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Skin warm
Clinical narrative: left arm is hot and red and a little itchy. I have been icing it.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dyspnoea
Clinical narrative: CHEST PAIN AND SHORTHNESS OF BREATH
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Nausea, Pain, Pyrexia
Clinical narrative: PT received 1st  dose of the Pfizer at 5:00PM (10/28/2021) from our facility. PT. called the Health Dept. at around 9:30 AM (10/29/2021). PT. stated that they experienced Nausea, Fever (103 F), Body aches, chills, and chest pain at 1 am this morning (approximately 8 hrs after receiving the first COVID-19 Pfizer vaccine.) PT stated that they took Tylenol and Zofran, but symptoms still persist. As of 10:45 AM we have referred the PT to seek their primary care physician for further assistance.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Lymphadenopathy, Paraesthesia oral, Tongue dry
Clinical narrative: SWOLLEN GALNS IN THROAT SINCE DATE OF VACCINE 9/10/21 TONGUE HAS BEEN TINGLING, FEELS DRY LIKE (SAND PAPER)  AND I HAVE LOST TASTE SINCE VAXX DATE 09/10/21
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Blood pressure increased, Chest X-ray, Chest pain, Chills
Clinical narrative: Fever Body Aches Chills Abdominal Cramps Random Cycle Bleeding Heavy Large Blood Clots Out of Nose and from Cycle  Sores on Arms Severe Chest Pains Blood Pressure Spikes
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Epistaxis, Heavy menstrual bleeding, Pain, Pain in extremity
Clinical narrative: Fever Body Aches Chills Abdominal Cramps Random Cycle Bleeding Heavy Large Blood Clots Out of Nose and from Cycle  Sores on Arms Severe Chest Pains Blood Pressure Spikes
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Specialist consultation, Thrombosis
Clinical narrative: Fever Body Aches Chills Abdominal Cramps Random Cycle Bleeding Heavy Large Blood Clots Out of Nose and from Cycle  Sores on Arms Severe Chest Pains Blood Pressure Spikes
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atelectasis, Auscultation, Back pain, Blood electrolytes normal, Blood lactic acid
Clinical narrative: Patient hospitalized.   On 10/27, patient was diagnosed with COVID-19 at his nursing home where he has been residing since discharge from the hospital in September after being treated for pneumonia with sepsis.  Patient was vaccinated with Moderna on 2/9/2021, 3/16/2021.  He was being followed by APNP for his COVID-19.  The nursing home reported abnormal lung sounds and some coughing which prompted a chest x-ray on 10/28 showing bilateral pleural effusions with a completely opacified right lung.  Patient presented to the emergency department   At the time of evaluation, patient was not reporting significant cough or shortness of breath.  He was down to 1 L nasal cannula.  Due to his history of cognitive impairment/dementia, he was unable to give details as to the history of his current condition.  He claims that he has been short of breath for many years, ever since being diagnosed with OSA.  Not feeling particularly more short of breath at this time.  Per chart review, patient had cough productive of phlegm. His primary concern was his back pain for which an L2 compression fracture was treated with kyphoplasty.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, COVID-19, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: Patient hospitalized.   On 10/27, patient was diagnosed with COVID-19 at his nursing home where he has been residing since discharge from the hospital in September after being treated for pneumonia with sepsis.  Patient was vaccinated with Moderna on 2/9/2021, 3/16/2021.  He was being followed by APNP for his COVID-19.  The nursing home reported abnormal lung sounds and some coughing which prompted a chest x-ray on 10/28 showing bilateral pleural effusions with a completely opacified right lung.  Patient presented to the emergency department   At the time of evaluation, patient was not reporting significant cough or shortness of breath.  He was down to 1 L nasal cannula.  Due to his history of cognitive impairment/dementia, he was unable to give details as to the history of his current condition.  He claims that he has been short of breath for many years, ever since being diagnosed with OSA.  Not feeling particularly more short of breath at this time.  Per chart review, patient had cough productive of phlegm. His primary concern was his back pain for which an L2 compression fracture was treated with kyphoplasty.